Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010

Authors: Changqing Li, Xiaopu Xiao, Huimin Yin, Miao He, Jianping Li, Yudong Dai, Yongshui Fu, Jianmin Ge, Yonglin Yang, Yan Luan, Changzhou Lin, Hongxiang Zhao, Wuping Li

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background

In China, high prevalence of HBV and HCV parallels with the growing epidemic of syphilis and HIV in the general population poses a great threat to blood safety. This study investigated the prevalence of serologic markers for transfusion transmissible infections (TTIs) among four Chinese blood centers.

Methods

We examined whole blood donations collected from January 2000 through December 2010 at four Chinese blood centers. Post-donation testing of TTIs (HIV, HBV, HCV and syphilis) were conducted using two different enzyme-linked immunosorbent assay kits for each seromarker. The prevalence of serologic markers for TTIs (%) was calculated and additional analysis was conducted to examine donor characteristics associated with positive TTIs serology.

Results

Of the 4,366,283 donations, 60% were from first-time donors and 40% were from repeated donors. The overall prevalence of HIV, HBsAg, HCV and syphilis was 0.08%, 0.86%, 0.51% and 0.47%, respectively. The prevalence profile of TTIs varied among different blood centers and appeared at relatively high levels. Overall, the prevalence of HBsAg and HCV demonstrated a decline trend among four blood centers, while the prevalence of HIV and syphilis displayed three different trends: constantly steady, continually increasing and declining among different centers.

Conclusions

This study reflects the risk of TTIs has been greatly reduced in China, but blood transfusion remains an ongoing risk factor for the spread of blood-borne infections, and further work and improvements are needed to strengthen both safety and availability of blood in China.
Appendix
Available only for authorised users
Literature
1.
go back to reference Allain JP, Thomas I, Sauleda S: Nucleic acid testing for emerging viral infections. Transfus Med. 2002, 12: 275-283. 10.1046/j.1365-3148.2002.00386.x.CrossRefPubMed Allain JP, Thomas I, Sauleda S: Nucleic acid testing for emerging viral infections. Transfus Med. 2002, 12: 275-283. 10.1046/j.1365-3148.2002.00386.x.CrossRefPubMed
2.
go back to reference Luban NL: Transfusion safety: Where are we today?. Ann N Y Acad Sci. 2005, 1054: 325-341. 10.1196/annals.1345.040.CrossRefPubMed Luban NL: Transfusion safety: Where are we today?. Ann N Y Acad Sci. 2005, 1054: 325-341. 10.1196/annals.1345.040.CrossRefPubMed
3.
go back to reference Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR: Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008, 48: 2205-2213. 10.1111/j.1537-2995.2008.01813.x.CrossRefPubMed Velati C, Romano L, Fomiatti L, Baruffi L, Zanetti AR: Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion. 2008, 48: 2205-2213. 10.1111/j.1537-2995.2008.01813.x.CrossRefPubMed
4.
go back to reference The progress of voluntary blood donation in our country. 2012, Report of Ministry of Health China The progress of voluntary blood donation in our country. 2012, Report of Ministry of Health China
5.
go back to reference Weeks MM, Abbott M, Liao S, Yu W, He B, Zhou Y, Wei L, Jiang J: Opportunities for woman-initiated HIV prevention methods among female sex workers in southern China. J Sex Res. 2007, 44: 190-201. 10.1080/00224490701263843.CrossRefPubMedPubMedCentral Weeks MM, Abbott M, Liao S, Yu W, He B, Zhou Y, Wei L, Jiang J: Opportunities for woman-initiated HIV prevention methods among female sex workers in southern China. J Sex Res. 2007, 44: 190-201. 10.1080/00224490701263843.CrossRefPubMedPubMedCentral
6.
go back to reference Wu Z, Rou K, Cui H: The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev. 2004, 16: 7-17. 10.1521/aeap.16.3.5.7.35521.CrossRefPubMed Wu Z, Rou K, Cui H: The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev. 2004, 16: 7-17. 10.1521/aeap.16.3.5.7.35521.CrossRefPubMed
7.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y: Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048.CrossRefPubMed Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y: Epidemiological serosurvey of hepatitis B in China–declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009, 27: 6550-6557. 10.1016/j.vaccine.2009.08.048.CrossRefPubMed
8.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y: Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis. 2009, 200: 39-47. 10.1086/599332.CrossRefPubMed Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y: Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis. 2009, 200: 39-47. 10.1086/599332.CrossRefPubMed
9.
go back to reference Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N: Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2012, 11: 88-CrossRef Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N: Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis. 2012, 11: 88-CrossRef
10.
go back to reference Luo Z, Li L, Ruan B: Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis. 2012, 16: e82-e88.CrossRefPubMed Luo Z, Li L, Ruan B: Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis. 2012, 16: e82-e88.CrossRefPubMed
11.
go back to reference Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011 Nov 5, 21 (6): 401-416. 10.2188/jea.JE20100190.CrossRefPubMedPubMedCentral Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011 Nov 5, 21 (6): 401-416. 10.2188/jea.JE20100190.CrossRefPubMedPubMedCentral
12.
go back to reference Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS, Cohen MS: Syphilis in China: results of a national surveillance programme. Lancet. 2007, 369: 132-138. 10.1016/S0140-6736(07)60074-9.CrossRefPubMed Chen ZQ, Zhang GC, Gong XD, Lin C, Gao X, Liang GJ, Yue XL, Chen XS, Cohen MS: Syphilis in China: results of a national surveillance programme. Lancet. 2007, 369: 132-138. 10.1016/S0140-6736(07)60074-9.CrossRefPubMed
13.
go back to reference Liu J, Huang Y, Wang J, Guo N, Li J, Dong X, Ma H, Tiemuer M, Huang M, Wright DJ: The increasing prevalence of serologic markers for syphilis among Chinese blood donors in 2008 through 2010 during a syphilis epidemic. Transfusion. Liu J, Huang Y, Wang J, Guo N, Li J, Dong X, Ma H, Tiemuer M, Huang M, Wright DJ: The increasing prevalence of serologic markers for syphilis among Chinese blood donors in 2008 through 2010 during a syphilis epidemic. Transfusion.
17.
go back to reference Shan HWJ, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM: Blood banking in China. Lancet. 2002, 360 (9347): 1770-1775. 10.1016/S0140-6736(02)11669-2.CrossRefPubMed Shan HWJ, Ren FR, Zhang YZ, Zhao HY, Gao GJ, Ji Y, Ness PM: Blood banking in China. Lancet. 2002, 360 (9347): 1770-1775. 10.1016/S0140-6736(02)11669-2.CrossRefPubMed
18.
go back to reference Meng ZH, YJ , Zhou HP, Yan LX: Retrospective study on HIV infection among blood donors in Zhejiang Province over 11-year period (1993–2004). Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006, 14 (6): 1231-1233.PubMed Meng ZH, YJ , Zhou HP, Yan LX: Retrospective study on HIV infection among blood donors in Zhejiang Province over 11-year period (1993–2004). Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006, 14 (6): 1231-1233.PubMed
19.
go back to reference Hong YHX, Ling H, Liao H: Prevalence and trend of HIV infection among voluntary blood donors in China since implementation of the blood donation law: a systematic review and meta-analysis. Trop Med Int Health. 2012, 10.1111/j.1365-3156.2012.03019.x. Epub ahead of print Hong YHX, Ling H, Liao H: Prevalence and trend of HIV infection among voluntary blood donors in China since implementation of the blood donation law: a systematic review and meta-analysis. Trop Med Int Health. 2012, 10.1111/j.1365-3156.2012.03019.x. Epub ahead of print
20.
go back to reference Gurol E, Saban C, Oral O, Cigdem A, Armagan A: Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemol. 2006, 21: 299-305. 10.1007/s10654-006-0001-2.CrossRef Gurol E, Saban C, Oral O, Cigdem A, Armagan A: Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemol. 2006, 21: 299-305. 10.1007/s10654-006-0001-2.CrossRef
21.
go back to reference Massarat MS T-MS: Iranian national health survey: a brief report. Arch Iranian Med. 2002, 5: 73-79. Massarat MS T-MS: Iranian national health survey: a brief report. Arch Iranian Med. 2002, 5: 73-79.
22.
go back to reference Soldan K, Barbara JA, Ramsay ME, Hall AJ: Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang. 2003, 84: 274-286. 10.1046/j.1423-0410.2003.00296.x.CrossRefPubMed Soldan K, Barbara JA, Ramsay ME, Hall AJ: Estimation of the risk of hepatitis B virus, hepatitis C virus and human immunodeficiency virus infectious donations entering the blood supply in England, 1993–2001. Vox Sang. 2003, 84: 274-286. 10.1046/j.1423-0410.2003.00296.x.CrossRefPubMed
23.
go back to reference Zou S, Notari EP, Stramer SL, Wahab F, Musavi F, Dodd RY: Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion. 2004, 44: 1640-1647. 10.1111/j.0041-1132.2004.04153.x.CrossRefPubMed Zou S, Notari EP, Stramer SL, Wahab F, Musavi F, Dodd RY: Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion. 2004, 44: 1640-1647. 10.1111/j.0041-1132.2004.04153.x.CrossRefPubMed
25.
go back to reference Zhao SM, Jiang TL, Gao FX, Lu L, Zheng HQ, Hu J, Fan YH, Li B, Xiao RR, Yury K: Analysis of true voluntary blood donors with anti-HCV prevalence and implications for donor management in Chongqing, China. Transfus Med. 2007, 17: 210-211. 10.1111/j.1365-3148.2007.00752.x.CrossRefPubMed Zhao SM, Jiang TL, Gao FX, Lu L, Zheng HQ, Hu J, Fan YH, Li B, Xiao RR, Yury K: Analysis of true voluntary blood donors with anti-HCV prevalence and implications for donor management in Chongqing, China. Transfus Med. 2007, 17: 210-211. 10.1111/j.1365-3148.2007.00752.x.CrossRefPubMed
26.
go back to reference Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR: Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion. 2005, 45: 1816-1822. 10.1111/j.1537-2995.2005.00611.x.CrossRefPubMed Ren FR, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, Liu CL, Wang JX, Yao FZ, Zheng YR: Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion. 2005, 45: 1816-1822. 10.1111/j.1537-2995.2005.00611.x.CrossRefPubMed
27.
go back to reference Lu YF, Yin P, Liu TY: Analysis on quality control of blood in blood banks in a five-year program in Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi. 2003, 24 (7): 574-576.PubMed Lu YF, Yin P, Liu TY: Analysis on quality control of blood in blood banks in a five-year program in Hunan province. Zhonghua Liu Xing Bing Xue Za Zhi. 2003, 24 (7): 574-576.PubMed
28.
go back to reference Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD: Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion. 2011 Dec, 51 (12): 2588-95. 10.1111/j.1537-2995.2011.03215.x.CrossRefPubMed Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD: Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion. 2011 Dec, 51 (12): 2588-95. 10.1111/j.1537-2995.2011.03215.x.CrossRefPubMed
29.
go back to reference Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH: A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Transfusion. 2007, 47: 2011-2016. 10.1111/j.1537-2995.2007.01424.x.CrossRefPubMed Shan H, Ren FR, Zhao HY, Zhang YZ, Wen GX, Yao FZ, Gao GJ, Yan LX, Jiang CF, Bai XH: A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing. Transfusion. 2007, 47: 2011-2016. 10.1111/j.1537-2995.2007.01424.x.CrossRefPubMed
30.
go back to reference Shang G, Seed CR, Wang F, Nie D, Farrugia A: Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion. 2007, 47: 529-539. 10.1111/j.1537-2995.2006.01146.x.CrossRefPubMed Shang G, Seed CR, Wang F, Nie D, Farrugia A: Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion. 2007, 47: 529-539. 10.1111/j.1537-2995.2006.01146.x.CrossRefPubMed
Metadata
Title
Prevalence and prevalence trends of transfusion transmissible infections among blood donors at four chinese regional blood centers between 2000 and 2010
Authors
Changqing Li
Xiaopu Xiao
Huimin Yin
Miao He
Jianping Li
Yudong Dai
Yongshui Fu
Jianmin Ge
Yonglin Yang
Yan Luan
Changzhou Lin
Hongxiang Zhao
Wuping Li
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-176

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine